It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...
A general view of U.S. Supreme Court in Washington, D.C., U.S., January 20, 2026. REUTERS/Nathan Howard The Supreme Court handed the Republican president a stinging defeat in a landmark ruling with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results